Cardiol Therapeutics Inc. Class A Common Shares — Institutional Ownership
Which tracked institutions hold CRDL, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
6
Funds holding
$796082
Total value held
Buying
4 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | $376332 | 355030 | +104609 | +41.77% |
| 2 | Goldman Sachs Group Inc | $353934 | 333900 | +1500 | +0.45% |
| 3 | Jpmorgan Chase & Co | $49519 | 48077 | — | Held |
| 4 | Ubs Group Ag | $8979 | 8471 | +8471 | NEW BUY |
| 5 | Royal Bank Of Canada | $7000 | 6729 | -14919 | -68.92% |
| 6 | Barclays Plc | $318 | 300 | +100 | +50.00% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.